The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
Business Of Biotech
00:00
What's the Quality of a CDMO?
Right now with the capacity crunch that we're facing it's really time is kind of the biggest thing that comes into play. And then CDMOs that have the right technology, you know whether they can support a gene therapy or cell therapy are one consideration. What quality systems does the CDMO have in place? Can analytical testing be done on site?"
Transcript
Play full episode
